Published on 9 Oct 2021 on Simply Wall St. via Yahoo Finance
As Edesa Biotech, Inc. (NASDAQ:EDSA) gains 11%, insiders who bought last year may be wishing they...
Edesa Biotech, Inc. (NASDAQ:EDSA) insiders who bought shares over the past year were rewarded handsomely last week. The stock rose 11%, resulting in a US$10m rise in the company's market capitalisation. As a result, the stock they originally bought for US$93k is now worth US$138k.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
See our latest analysis for Edesa Biotech